Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

NIQ GLOBAL INTELLIGENCE PLC ORDINARY SHARES (NIQ)

  • Business News
  • March 13, 2026, 22:29 UTC
  • 0
  • 1 comments

NIQ在Ask Arthur中推出全新AI驅動分析功能的測試版

Market reaction Comment Full text

NIQ GLOBAL INTELLIGENCE PLC ORDINARY SHARES (NIQ)

  • Business News
  • March 13, 2026, 22:29 UTC
  • 1
  • 1 comments

NIQ startet Betaphase neuer KI-gestützter Analysefunktionen in Ask Arthur

Market reaction Comment Full text

NIQ GLOBAL INTELLIGENCE PLC ORDINARY SHARES (NIQ)

  • Business News
  • March 13, 2026, 22:29 UTC
  • 1
  • 1 comments

NIQ在Ask Arthur中推出全新AI驱动分析功能的测试版

Market reaction Comment Full text

NIQ GLOBAL INTELLIGENCE PLC ORDINARY SHARES (NIQ)

  • Business News
  • March 13, 2026, 22:29 UTC
  • 1
  • 1 comments

NIQ lancia la versione beta di nuove funzionalità analitiche basate sullAI in Ask Arthur

Market reaction Comment Full text

NIQ GLOBAL INTELLIGENCE PLC ORDINARY SHARES (NIQ)

  • Business News
  • March 13, 2026, 22:29 UTC
  • 1
  • 1 comments

NIQ lanceert bèta van nieuwe, door AI aangestuurde analytische capaciteiten in Ask Arthur

Market reaction Comment Full text

SERA PROGNOSTICS, INC. (SERA)

  • SEC News
  • March 13, 2026, 22:28 UTC
  • 1
  • 1 comments

Lindgardt Zhenya 🟢 acquired 393.9K shares (1 derivative) of SERA PROGNOSTICS, INC. (SERA) at $1.99 Transaction Date: Mar 12, 2026 | Filing ID: 106593

Comment Full text

SERA PROGNOSTICS, INC. (SERA)

  • SEC News
  • March 13, 2026, 22:28 UTC
  • 1
  • 1 comments

Jackson Benjamin 🟢 acquired 112.8K shares (1 derivative) of SERA PROGNOSTICS, INC. (SERA) at $1.99 Transaction Date: Mar 12, 2026 | Filing ID: 106591

Comment Full text

SILVERCREST ASSET MANAGEMENT GROUP INC. (SAMG)

  • Business News
  • March 13, 2026, 22:28 UTC
  • 1
  • 1 comments

Silvercrest Asset Management (SAMG) to Announce Fourth Quarter and Year-End 2025 Results and Host Investor Conference Call

Market reaction Comment Full text

SERA PROGNOSTICS, INC. (SERA)

  • SEC News
  • March 13, 2026, 22:28 UTC
  • 1
  • 1 comments

Inglis Tiffany Eul Davis 🟢 acquired 44.5K shares (1 derivative) of SERA PROGNOSTICS, INC. (SERA) at $1.99 Transaction Date: Mar 12, 2026 | Filing ID: 106590

Comment Full text

SERA PROGNOSTICS, INC. (SERA)

  • SEC News
  • March 13, 2026, 22:27 UTC
  • 1
  • 1 comments

Anderson Dyaarl Lee Jr. 🟢 acquired 31.8K shares (1 derivative) of SERA PROGNOSTICS, INC. (SERA) at $1.99 Transaction Date: Mar 12, 2026 | Filing ID: 106589

Comment Full text

SERA PROGNOSTICS, INC. (SERA)

  • SEC News
  • March 13, 2026, 22:27 UTC
  • 1
  • 1 comments

Aerts Austin 🟢 acquired 112.8K shares (1 derivative) of SERA PROGNOSTICS, INC. (SERA) at $1.99 Transaction Date: Mar 12, 2026 | Filing ID: 106588

Comment Full text

CENTESSA PHARMACEUTICALS PLC (CNTA)

  • SEC News
  • March 13, 2026, 22:23 UTC
  • 1
  • 1 comments

Anderson Karen M. 🟡 adjusted position in 120.0K shares (1 derivative) of Centessa Pharmaceuticals plc (CNTA) at $27.13 ($4.0M) Transaction Date: Mar 13, 2026 | Filing ID: 000268

Comment Full text

CENTESSA PHARMACEUTICALS PLC (CNTA)

  • SEC News
  • March 13, 2026, 22:22 UTC
  • 1
  • 1 comments

Weinhoff Gregory M 🔴 sold 73.2K shares of Centessa Pharmaceuticals plc (CNTA) at $27.16 ($1.9M) Transaction Date: Mar 13, 2026 | Filing ID: 000267

Comment Full text

INSULET CORPORATION (PODD)

  • Business News
  • March 13, 2026, 22:21 UTC
  • 1
  • 1 comments

Securities Fraud Investigation Into Insulet Corporation (PODD) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Market reaction Comment Full text

PICARD MEDICAL, INC. (PMI)

  • Business News
  • March 13, 2026, 22:20 UTC
  • 3
  • 1 comments

PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit

Market reaction Comment Full text
  • Previous
  • 6
  • 7
  • 8
  • 9
  • 10
  • Next

Search

News categories

  • Technical Exchange News(11221)
  • Event(2606)
  • SEC News(198256)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(130849)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin